| Dr Ty Hanson, DO | |
|
3 Lafayette St S, Aberdeen, SD 57401-5524 | |
| (605) 226-0560 | |
| (605) 226-1653 |
| Full Name | Dr Ty Hanson |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 3 Lafayette St S, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396804597 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Lukes | Aberdeen, SD | Hospital |
| Community Memorial Hospital | Redfield, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prairie Dermatology Pc | 7719079193 | 3 |
News Archive
Scientists from the Johns Hopkins University School of Medicine, USA, have recently developed an Antibody Display technology by grafting the second extracellular domain of tetraspanin12 (Tspan12EC2) and the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein on the heavy chain complementarity-determining region 3 (CDR3).
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.
› Verified 1 days ago
| Entity Name | Prairie Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164622098 PECOS PAC ID: 7719079193 Enrollment ID: O20070816000019 |
News Archive
Scientists from the Johns Hopkins University School of Medicine, USA, have recently developed an Antibody Display technology by grafting the second extracellular domain of tetraspanin12 (Tspan12EC2) and the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein on the heavy chain complementarity-determining region 3 (CDR3).
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ty Hanson, DO 3 Lafayette St S, Aberdeen, SD 57401-5524 Ph: (605) 226-0560 | Dr Ty Hanson, DO 3 Lafayette St S, Aberdeen, SD 57401-5524 Ph: (605) 226-0560 |
News Archive
Scientists from the Johns Hopkins University School of Medicine, USA, have recently developed an Antibody Display technology by grafting the second extracellular domain of tetraspanin12 (Tspan12EC2) and the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein on the heavy chain complementarity-determining region 3 (CDR3).
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.
› Verified 1 days ago
Dr. Bo Wang, MD, PHD Dermatology Medicare: Medicare Enrolled Practice Location: 105 S State St Ste 202, Aberdeen, SD 57401 Phone: 605-622-8960 Fax: 605-622-8961 | |
Dr. Warren John Redmond, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 201 S Lloyd St, E206, Aberdeen, SD 57401 Phone: 605-226-0560 Fax: 605-226-1653 |